CHRIS AMOS to Thrombotic Microangiopathies
This is a "connection" page, showing publications CHRIS AMOS has written about Thrombotic Microangiopathies.
Connection Strength
0.553
-
Prospective Clinical and Biomarker Validation of the American Society for Transplantation and Cellular Therapy Consensus Definition for Transplantation-Associated Thrombotic Microangiopathy. Transplant Cell Ther. 2023 11; 29(11):685.e1-685.e7.
Score: 0.195
-
Pathway-driven rare germline variants associated with transplant-associated thrombotic microangiopathy (TA-TMA). Thromb Res. 2023 05; 225:39-46.
Score: 0.189
-
Thrombotic Microangiopathy Increases the Risk of Chronic Kidney Disease but Not Overall Mortality in Long-term Transplant Survivors. Transplant Cell Ther. 2021 10; 27(10):864.e1-864.e5.
Score: 0.168